Publications
-
China Announcing More Proposed Amendments to the Examination Guidelines in 2022
- November 17, 2022
- Posted by: admin
- Category: Publications
No CommentsChina Announcing More Proposed Amendments to the Examination Guidelines in 2022 November 2022 It’s been a year and a half since the new Chinese Patent Law came into effect (1 June 2021). Although various versions of draft Examination Guidelines have been released, thus far no official finalized versions have been confirmed. On October 31, 2022, -
US vs CN: National Security Clearance Requirements
- November 9, 2022
- Posted by: admin
- Category: Publications
US vs CN: National Security Clearance Requirements November 2022 In China, national security and foreign filing requirements are generally very similar to the US system—a foreign filing license is required if a foreign application is to be filed for an invention made in this country. The Chinese equivalent to the US foreign filing license is -
Compositions Limited by Use: A Cautionary Tale
- October 26, 2022
- Posted by: admin
- Category: Publications
Compositions Limited by Use: A Cautionary Tale October 2022 Section 4.2.3, Part II Chapter 10 of the CNIPA's Examination Guidelines ("Guidelines") stipulates that if the specification only discloses one property or use of a composition, the composition claim shall be drafted as a "composition limited by the function or the use". Furthermore, it specifically states -
How the Chinese Patent Office Rejected a Plate-Making Method Based on Food Safety Law
- October 20, 2022
- Posted by: admin
- Category: Publications
How the Chinese Patent Office Rejected a Plate-Making Method Based on Food Safety Law October 2022 Previously we published an article about CNIPA rejecting a patent application claiming a food that could also be used to treat or prevent diseases based on the food's alleged non-compliance with Food Safety Law. China's Food Safety Law includes -
China’s Supreme People’s Court (SPC) Hands Down First Patent Linkage Appeal Decision
- September 21, 2022
- Posted by: admin
- Category: Publications
China’s Supreme People’s Court (SPC) Hands Down First Patent Linkage Appeal Decision September 2022 China has been implementing a plethora of new laws and measures that are particularly favorable to drug companies, such as patent term extension and patent linkage. Details of the new implementation measures for patent linkage (technically “early dispute resolution mechanisms for -
Eagle IP is Recognized in IP Stars 2022 in Patent Prosecution
- September 20, 2022
- Posted by: admin
- Category: Publications
Eagle IP is Recognized in IP Stars 2022 in Patent Prosecution September 2022 We are delighted to share that Eagle IP has been ranked in IP Stars 2022, from Managing IP, for our expertise in Patent Prosecution. Our President Dr. Jacqueline Lui is also ranked as a Patent Star 2022. We are honored to be -
Eagle IP is Recognized in IAM Patent 1000 as a Top Tier Firm
- July 7, 2022
- Posted by: admin
- Category: Publications
Eagle IP is Recognized in IAM Patent 1000 as a Top Tier Firm July 2022 We are delighted to share that Eagle IP has been recognized by IAM Patent 1000 as a Highly-Recommended Firm for our expertise in Prosecution. Our President Dr. Jacqueline Lui and Vice President and Principal Ms. Jennifer Che are also ranked -
SPC Upholds $2M RMB Award in China’s First Patent Case on a Biological Deposit
- July 4, 2022
- Posted by: admin
- Category: Publications
SPC Upholds $2M RMB Award in China's First Patent Case on a Biological Deposit July 2022 On 28 Feb 2022, China's Supreme People's Court (SPC) issued its annual "Judgment Digests", which includes a list of "48 typical cases" highlighting representative SPC decisions in 2021. The Judgment Digests help us understand more about the SPC's judicial -
China Hands Down First Batch of Patent Linkage “Paragraph IV” Litigation Results
- June 30, 2022
- Posted by: admin
- Category: Publications
China Hands Down First Batch of Patent Linkage "Paragraph IV" Litigation Results June 2022 China has been implementing a plethora of new laws and measures that are particularly favorable to drug companies, such as patent term extension and patent linkage. Details of the new implementation measures for patent linkage (technically "early dispute resolution mechanisms for -
What Kind of Damage Awards Can You Get in China?
- June 17, 2022
- Posted by: admin
- Category: Publications
What Kind of Damage Awards Can You Get in China? June 2022 Is it worth filing for a patent in China? What kind of damage awards can you get? Pharma companies care more about injunction than damage awards, since it's quite unlikely that any damage award can compensate for the large amounts of money